Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Details
Obrambni izdatki in vojaška moč : primer Ruske federacije
ID
Grželj, Alen
(
Author
),
ID
Kopač, Erik
(
Mentor
)
More about this mentor...
URL - Presentation file, Visit
http://dk.fdv.uni-lj.si/diplomska_dela_1/pdfs/mb11_grzelj-alen.pdf
Image galllery
Language:
Slovenian
Keywords:
Ruska federacija
,
obrambni izdatki
Work type:
Bachelor thesis/paper
Typology:
2.11 - Undergraduate Thesis
Organization:
FDV - Faculty of Social Sciences
Place of publishing:
Ljubljana
Publisher:
[A. Grželj]
Year:
2015
Number of pages:
40 str.
PID:
20.500.12556/RUL-73645
UDC:
336.5:355.02(470+571)(043.2)
COBISS.SI-ID:
33623389
Publication date in RUL:
21.11.2015
Views:
2208
Downloads:
204
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
GRŽELJ, Alen, 2015,
Obrambni izdatki in vojaška moč : primer Ruske federacije
[online]. Bachelor’s thesis. Ljubljana : A. Grželj. [Accessed 3 April 2025]. Retrieved from: http://dk.fdv.uni-lj.si/diplomska_dela_1/pdfs/mb11_grzelj-alen.pdf
Copy citation
Share:
Similar documents
Similar works from RUL:
Načrtovanje sončne elektrarne in baterijskega hranilnika s ciljem energetske samooskrbe podjetja
Analiza investicij v sončne elektrarne v Sloveniji
Vpliv hlajenja fotonapetostnih celic na njihovo vršno moč in proizvodnjo električne energije
Projektno učno delo s pomočjo 3D tiska v 8. razredu osnovne šole
Pridobivanje energije s pomočjo sončnih celic na izbrani kmetiji
Similar works from other Slovenian collections:
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
Outsourcing predictive biomarker testing in non-small cell carcinoma
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
NSCLC molecular testing in Central and Eastern European countries
Back